Concerted loss of TGFβ-mediated proliferation control and E-cadherin disrupts epithelial homeostasis and causes oral squamous cell carcinoma

Carcinogenesis

Volumn 35, Issue 11, 2014, Pages 2602-2610

  Andl, Thomas ^a   Le Bras, Grégoire F ^a   Richards, Nicole F ^a   Allison, Gillian L ^a   Loomans, Holli A ^b   Kay Washington, M ^a,c,d   Revetta, Frank ^a,c,d   Lee, Rebecca K ^a   Taylor, Chase ^a   Moses, Harold L ^b,c   Andl, Claudia D ^a,b,c,d  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VANDERBILT INGRAM CANCER CENTER   (United States)

^d Vanderbilt Digestive Disease Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; MYC PROTEIN; TRANSCRIPTION FACTOR YAP1; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2; UVOMORULIN; CADHERIN; CCND1 PROTEIN, HUMAN; CDH1 PROTEIN, HUMAN; PROTEIN SERINE THREONINE KINASE; TAMOXIFEN; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR-BETA TYPE II RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; DISTANT METASTASIS; EPSTEIN BARR VIRUS; ESOPHAGUS; ESOPHAGUS MUCOSA; FORESTOMACH; GENE DELETION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LUNG METASTASIS; LYMPH NODE; MOUSE; MOUTH MUCOSA; MOUTH SQUAMOUS CELL CARCINOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TONGUE; TUMOR INVASION; UPREGULATION; ANIMAL; BIOSYNTHESIS; CELL PROLIFERATION; EPITHELIUM CELL; GENETICS; HOMEOSTASIS; METABOLISM; MOUTH TUMOR; PATHOLOGY; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA;

ANIMALS; CADHERINS; CARCINOGENESIS; CARCINOMA, SQUAMOUS CELL; CELL PROLIFERATION; CYCLIN D1; EPITHELIAL CELLS; HOMEOSTASIS; HUMANS; MICE; MOUTH NEOPLASMS; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SIGNAL TRANSDUCTION; TAMOXIFEN;

EID: 84965191032     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgu194     Document Type: Article

References (61)

1. Thiery, J.P. (2002) Epithelial-mesenchymal transitions in tumour progression. Nat. Rev. Cancer, 2, 442-454.
2. Vleminckx, K. et al. (1991) Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell, 66, 107-119.
3. Bosch, F.X. et al. (2005) E-cadherin is a selective and strongly dominant prognostic factor in squamous cell carcinoma: a comparison of E-cadherin with desmosomal components. Int. J. Cancer, 114, 779-790.
4. Behrens, J. et al. (1989) Dissecting tumor cell invasion: epithelial cells acquire invasive properties after the loss of uvomorulin-mediated cell-cell adhesion. J. Cell Biol., 108, 2435-2447.
5. Peifer, M. et al. (2000) Wnt signaling in oncogenesis and embryogenesis-a look outside the nucleus. Science, 287, 1606-1609.
6. Fagotto, F. et al. (1996) Binding to cadherins antagonizes the signaling activity of beta-catenin during axis formation in Xenopus. J. Cell Biol., 132, 1105-1114.
7. Sanson, B. et al. (1996) Uncoupling cadherin-based adhesion from wingless signalling in Drosophila. Nature, 383, 627-630.
8. Tunggal, J.A. et al. (2005) E-cadherin is essential for in vivo epidermal barrier function by regulating tight junctions. EMBO J., 24, 1146-1156.
9. Tinkle, C.L. et al. (2004) Conditional targeting of E-cadherin in skin: insights into hyperproliferative and degenerative responses. Proc. Natl Acad. Sci. U.S.A., 101, 552-557.
10. Katsuno, Y. et al. (2013) TGF-ß signaling and epithelial-mesenchymal transition in cancer progression. Curr. Opin. Oncol., 25, 76-84.
11. Cheng, C.F. et al. (2008) Profiling motility signal-specific genes in primary human keratinocytes. J. Invest. Dermatol., 128, 1981-1990.
12. Levy, L. et al. (2005) Smad4 dependency defines two classes of transforming growth factor beta target genes and distinguishes TGFß-induced epithelial-mesenchymal transition from its antiproliferative and migratory responses. Mol. Cell Biol., 25, 8108-8125.
13. Vijayachandra, K. et al. (2009) Induction of p16ink4a and p19ARF by TGFbeta1 contributes to growth arrest and senescence response in mouse keratinocytes. Mol. Carcinog., 48, 181-186.
14. Forrester, E. et al. (2005) Effect of conditional knockout of the type II TGFbeta receptor gene in mammary epithelia on mammary gland development and polyomavirus middle T antigen induced tumor formation and metastasis. Cancer Res., 65, 2296-2302.
15. Gorska, A.E. et al. (2003) Transgenic mice expressing a dominant-negative mutant type II transforming growth factor-beta receptor exhibit impaired mammary development and enhanced mammary tumor formation. Am. J. Pathol., 163, 1539-1549.
16. Dong, Z. et al. (2012) Concordant promoter methylation of transforming growth factor-beta receptor types I and II occurs early in esophageal squamous cell carcinoma. Am. J. Med. Sci., 343, 375-381.
17. Wang, J. et al. (1995) Demonstration that mutation of the type II transforming growth factor beta receptor inactivates its tumor suppressor activity in replication error-positive colon carcinoma cells. J. Biol. Chem., 270, 22044-22049.
18. Turco, A. et al. (1999) Overexpression of transforming growth factor betatype II receptor reduces tumorigenicity and metastastic potential of K-rastransformed thyroid cells. Int. J. Cancer, 80, 85-91.
19. Andl, C.D. et al. (2006) Coordinated functions of E-cadherin and transforming growth factor beta receptor II in vitro and in vivo. Cancer Res., 66, 9878-9885.
20. Andl, C.D. et al. (2010) Cathepsin B is the driving force of esophageal cell invasion in a fibroblast-dependent manner. Neoplasia, 12, 485-498.
21. Cerami, E. et al. (2012) The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov., 2, 401-404.
22. Gao, J. et al. (2013) Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci. Signal., 6, pl1.
23. Tetreault, M.P. et al. (2010) Esophageal squamous cell dysplasia and delayed differentiation with deletion of krüppel-like factor 4 in murine esophagus. Gastroenterology, 139, 171-181.e9.
24. Chytil, A. et al. (2002) Conditional inactivation of the TGF-beta type II receptor using Cre:Lox. Genesis, 32, 73-75.
25. India Project Team of the International Cancer Genome Consortium (2013) Mutational landscape of gingivo-buccal oral squamous cell carcinoma reveals new recurrently-mutated genes and molecular subgroups. Nat. Commun., 4, 2873.
26. Zhang, L. et al. (2011) Yes-associated protein promotes cell proliferation by activating Fos related activator-1 in oral squamous cell carcinoma. Oral Oncol., 47, 693-697.
27. Kim, N.G. et al. (2011) E-cadherin mediates contact inhibition of proliferation through Hippo signaling-pathway components. Proc. Natl Acad. Sci. U.S.A., 108, 11930-11935.
28. Stockinger, A. et al. (2001) E-cadherin regulates cell growth by modulating proliferation-dependent beta-catenin transcriptional activity. J. Cell Biol., 154, 1185-1196.
29. Jones, P.H. et al. (1993) Separation of human epidermal stem cells from transit amplifying cells on the basis of differences in integrin function and expression. Cell, 73, 713-24.
30. Seery, J.P. et al. (2000) Asymmetric stem-cell divisions define the architecture of human oesophageal epithelium. Curr. Biol., 10, 1447-1450.
31. Lin, H.K. et al. (2004) Cytoplasmic PML function in TGF-beta signalling. Nature, 431, 205-211.
32. Tang, M.K. et al. (2013) Promyelocytic leukemia (PML) protein plays important roles in regulating cell adhesion, morphology, proliferation and migration. PLoS One, 8, e59477.
33. Piek, E. et al. (2001) Suppressor and oncogenic roles of transforming growth factor-beta and its signaling pathways in tumorigenesis. Adv. Cancer Res., 83, 1-54.
34. Chen, T. et al. (2001) Novel inactivating mutations of transforming growth factor-beta type I receptor gene in head-and-neck cancer metastases. Int. J. Cancer, 93, 653-661.
35. Sivadas, V.P. et al. (2013) Novel mutations and expression alterations in SMAD3/TGFBR2 genes in oral carcinoma correlate with poor prognosis. Genes Chromosomes Cancer, 52, 1042-1052.
36. 3 and mammalian target of rapamycin. Stem Cells, 26, 3150-3161.
37. Moreno, S.G. et al. (2010) TGFbeta signaling in male germ cells regulates gonocyte quiescence and fertility in mice. Dev. Biol., 342, 74-84.
38. Nishimura, E.K. et al. (2010) Key roles for transforming growth factor beta in melanocyte stem cell maintenance. Cell Stem Cell, 6, 130-140.
39. Sakaki-Yumoto, M. et al. (2013) TGF-ß family signaling in stem cells. Biochim. Biophys. Acta, 1830, 2280-2296.
40. Ye, J. et al. (2012) Enrichment of colorectal cancer stem cells through epithelial-mesenchymal transition via CDH1 knockdown. Mol. Med. Rep., 6, 507-512.
41. Geng, S. et al. (2013) Cancer stem-like cells enriched with CD29 and CD44 markers exhibit molecular characteristics with epithelial-mesenchymal transition in squamous cell carcinoma. Arch. Dermatol. Res., 305, 35-47.
42. La Fleur, L. et al. (2012) A CD44high/EGFRlow subpopulation within head and neck cancer cell lines shows an epithelial-mesenchymal transition phenotype and resistance to treatment. PLoS One, 7, e44071.
43. Stairs, D.B. et al. (2011) Deletion of p120-catenin results in a tumor microenvironment with inflammation and cancer that establishes it as a tumor suppressor gene. Cancer Cell, 19, 470-483.
44. Vitsky, A. et al. (2009) Homeostatic role of transforming growth factor-beta in the oral cavity and esophagus of mice and its expression by mast cells in these tissues. Am. J. Pathol., 174, 2137-2149.
45. Bhowmick, N.A. et al. (2004) TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia. Science, 303, 848-851.
46. Wang, X. et al. (2009) Growth inhibition induced by transforming growth factorbeta1 in human oral squamous cell carcinoma. Mol. Biol. Rep., 36, 861-869.
47. Bornstein, S. et al. (2009) Smad4 loss in mice causes spontaneous head and neck cancer with increased genomic instability and inflammation. J. Clin. Invest., 119, 3408-3419.
48. Teng, Y. et al. (2006) Synergistic function of Smad4 and PTEN in suppressing forestomach squamous cell carcinoma in the mouse. Cancer Res., 66, 6972-6981.
49. Bian, Y. et al. (2012) Loss of TGF-ß signaling and PTEN promotes head and neck squamous cell carcinoma through cellular senescence evasion and cancer-related inflammation. Oncogene, 31, 3322-3332.
50. Sun, Z.J. et al. (2012) Chemopreventive and chemotherapeutic actions of mTOR inhibitor in genetically defined head and neck squamous cell carcinoma mouse model. Clin. Cancer Res., 18, 5304-5313.
51. Herzog, A. et al. (2013) PI3K/mTOR inhibitor PF-04691502 antitumor activity is enhanced with induction of wild-type TP53 in human xenograft and murine knockout models of head and neck cancer. Clin. Cancer Res., 19, 3808-3819.
52. Guasch, G. et al. (2007) Loss of TGFbeta signaling destabilizes homeostasis and promotes squamous cell carcinomas in stratified epithelia. Cancer Cell, 12, 313-327.
53. Pickering, C.R. et al. (2013) Integrative genomic characterization of oral squamous cell carcinoma identifies frequent somatic drivers. Cancer Discov., 3, 770-781.
54. Warner, B.J. et al. (1999) Myc downregulation by transforming growth factor beta required for activation of the p15(Ink4b) G(1) arrest pathway. Mol. Cell. Biol., 19, 5913-5922.
55. Ohashi, S. et al. (2011) A NOTCH3-mediated squamous cell differentiation program limits expansion of EMT-competent cells that express the ZEB transcription factors. Cancer Res., 71, 6836-6847.
56. Sudol, M. (2012) WW domains in the heart of Smad regulation. Structure, 20, 1619-1620.
57. Zhang, H. et al. (2014) Yap1 is required for endothelial to mesenchymal transition of the atrioventricular cushion. J. Biol. Chem., 289, 18681-18692.
58. Hiemer, S.E. et al. (2014) The transcriptional regulators TAZ and YAP direct transforming growth factor ß-induced tumorigenic phenotypes in breast cancer cells. J. Biol. Chem., 289, 13461-13474.
59. Varelas, X. et al. (2010) The Crumbs complex couples cell density sensing to Hippo-dependent control of the TGF-ß-SMAD pathway. Dev. Cell, 19, 831-844.
60. Chen, C.L. et al. (2013) Reciprocal regulation by TLR4 and TGF-ß in tumor-initiating stem-like cells. J. Clin. Invest., 123, 2832-2849.
61. Schlegelmilch, K. et al. (2011) Yap1 acts downstream of α-catenin to control epidermal proliferation. Cell, 144, 782-795.